RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 69 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q4 2013. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $30,702,000 | +68.3% | 3,422,721 | +0.7% | 0.00% | +100.0% |
| Q2 2016 | $18,246,000 | +16.3% | 3,397,625 | -0.3% | 0.00% | 0.0% |
| Q1 2016 | $15,682,000 | +0.0% | 3,409,186 | +13.1% | 0.00% | 0.0% |
| Q4 2015 | $15,676,000 | -7.5% | 3,014,796 | +7.6% | 0.00% | 0.0% |
| Q3 2015 | $16,948,000 | -60.5% | 2,801,359 | +3.0% | 0.00% | -66.7% |
| Q2 2015 | $42,946,000 | +79.4% | 2,719,816 | +23.5% | 0.00% | +50.0% |
| Q1 2015 | $23,945,000 | +9.8% | 2,202,880 | +6.3% | 0.00% | 0.0% |
| Q4 2014 | $21,802,000 | +15.8% | 2,072,463 | +5.5% | 0.00% | +100.0% |
| Q3 2014 | $18,835,000 | -14.5% | 1,964,012 | +3.0% | 0.00% | -50.0% |
| Q2 2014 | $22,021,000 | +18.5% | 1,906,499 | +2.6% | 0.00% | 0.0% |
| Q1 2014 | $18,586,000 | -16.6% | 1,858,542 | +8.5% | 0.00% | 0.0% |
| Q4 2013 | $22,296,000 | -5.1% | 1,712,495 | +8.9% | 0.00% | 0.0% |
| Q3 2013 | $23,501,000 | +99.1% | 1,573,043 | +24.6% | 0.00% | +100.0% |
| Q2 2013 | $11,803,000 | – | 1,262,314 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parametrica Management Ltd | 16,355 | $244,000 | 3.04% |
| EAM Investors, LLC | 175,761 | $2,626,000 | 0.52% |
| Tekla Capital Management LLC | 110,000 | $1,643,000 | 0.18% |
| Jane Street Holding, LLC | 447,456 | $6,676,000 | 0.08% |
| A.R.T. Advisors, LLC | 95,164 | $1,419,000 | 0.08% |
| CREDIT SUISSE AG/ | 5,079,886 | $75,792,000 | 0.08% |
| NOMURA HOLDINGS INC | 736,362 | $10,936,000 | 0.07% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,000,000 | $14,920,000 | 0.04% |
| ROYAL BANK OF CANADA | 2,971,616 | $44,337,000 | 0.03% |
| LORD, ABBETT & CO. LLC | 721,849 | $10,784,000 | 0.02% |